| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/26/2000 | EP0995758A1 Physiologically active polyoxypeptin and deoxypolyoxypeptin and anticancer drugs containing the same |
| 04/26/2000 | EP0995445A2 Ligand-mediated immunofunctional hormone binding protein assay method |
| 04/26/2000 | EP0995121A1 C-peptide specific assay procedure |
| 04/26/2000 | EP0994966A1 Member of the tnf family useful for treatment and diagnosis of disease |
| 04/26/2000 | EP0994954A1 T7 promoter-based expression system |
| 04/26/2000 | EP0994953A1 Expression system for production of therapeutic proteins |
| 04/26/2000 | EP0994951A1 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin b and related compounds |
| 04/26/2000 | EP0994949A1 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
| 04/26/2000 | EP0994947A1 Mu-1, member of the cytokine receptor family |
| 04/26/2000 | EP0994946A1 Coding sequence haplotypes of the human brca2 gene |
| 04/26/2000 | EP0994943A2 Method of altering the domains of cyclosporin synthetase to give a modified cyclosporin synthetase |
| 04/26/2000 | EP0994904A2 AMINO ACID SEQUENCES FOR THERAPEUTICAL AND PROPHYLACTIC APPLICATIONS TO DISEASES DUE TO $i(CLOSTRIDIUM DIFFICILE) TOXINS |
| 04/26/2000 | EP0994903A1 Methods and compositions for galactosylated glycoproteins |
| 04/26/2000 | EP0994900A1 Semaphorin receptors |
| 04/26/2000 | EP0994728A1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 04/26/2000 | EP0994724A1 Methods and compositions for impairing multiplication of hiv-1 |
| 04/26/2000 | EP0925305B1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity |
| 04/26/2000 | EP0925304B1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism |
| 04/26/2000 | EP0832108B1 Process for recovering water-insoluble compounds from a fermentation broth |
| 04/26/2000 | EP0789716B1 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof |
| 04/26/2000 | EP0736102B1 Method for preparing peptide products |
| 04/26/2000 | EP0656945B1 Stress protein epitopes |
| 04/26/2000 | EP0656013B1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 04/26/2000 | CN1251614A New EIA test using non-dentured HIV antigen for early detection of HIV infection |
| 04/26/2000 | CN1251610A Novel mouse CXC chemokine receptor |
| 04/26/2000 | CN1251390A Human guanosine monophophate reductase and its coding sequence and preparation method |
| 04/26/2000 | CN1251389A Ligand for regulating exogenic expression through molting hormone receptor complex |
| 04/26/2000 | CN1251371A Exciter for inducing allergic reaction of plant and preparation method and use thereof |
| 04/26/2000 | CN1051769C Parathyroid hormone analogues, their production method and medicinal composition containing same |
| 04/25/2000 | US6054572 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 04/25/2000 | US6054567 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 04/25/2000 | US6054560 Mitogen activated protein kinase, FRK |
| 04/25/2000 | US6054559 Interleukin-1 receptor antagonist beta (IL-1raβ) |
| 04/25/2000 | US6054431 Anti-gram-positive bacterial methods and materials |
| 04/25/2000 | US6054321 Forming three-dimensional structure of a fluorescent protein, constructing model of other fluorescent protein using first as template, making mutants by replacing amino acid(s) within 5 angstroms of any atom of chromophore |
| 04/25/2000 | US6054313 For diagnosis of persistant hyperinsulinemic hypoglycemia of infancy; for screening drugs and antidiabetic agents; for gene therapy |
| 04/25/2000 | US6054301 Methods of amplification using a thermostable DNA polymerase from the hyperthermophilic archaeon strain KOD1 and reagent kit therefor |
| 04/25/2000 | US6054297 Preparing humanized immunoglobulin from complimentarity and human framework region; obtaining human and mammalian variable domain sequences, detecting, replacing, and adjusting sequences, detect binding, prepare immunoglobulin |
| 04/25/2000 | US6054296 66 kDa antigen from Borrelia |
| 04/25/2000 | US6054293 Polypeptide involved in chemotatic response; screening for modulator proteins involved in nerve cell migration |
| 04/25/2000 | US6054292 T-cell receptor protein |
| 04/25/2000 | US6054284 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use |
| 04/25/2000 | US6054163 Used as a food preservative |
| 04/25/2000 | US6054132 A purified toxin in diagnostic testing for detecting peptic ulceration and gastric malignancy, and as a vaccine for providing immunologic protection against bacterial infection |
| 04/25/2000 | US6054130 Non-splicing variants of gp350/220 |
| 04/25/2000 | US6054126 A synthetic polypeptide containing the conformational epitope recognized by monoclonal antibody mab 17-82 for neutralizing antibodies in an avian host; stimulating an immune response against infectious bursal disease virus in poultry |
| 04/25/2000 | CA2155762C Protein modification method |
| 04/25/2000 | CA2155728C Regulated transcription of targeted genes and other biological events |
| 04/25/2000 | CA2019803C Feline interferon and process for production thereof |
| 04/25/2000 | CA1340977C Scavenger receptor protein and antibody thereto |
| 04/25/2000 | CA1340973C Immunometric assay kit and method applicable to whole cells |
| 04/25/2000 | CA1340972C Follistatin and method of purifying same |
| 04/25/2000 | CA1340970C Lipase from gastric mucosa |
| 04/20/2000 | WO2000022439A2 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 04/20/2000 | WO2000022430A2 Neisseria genomic sequences and methods of their use |
| 04/20/2000 | WO2000022156A1 Antibody against glycerylaldehyde-3-phosphate dehydrogenase and utilization thereof |
| 04/20/2000 | WO2000022146A1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II |
| 04/20/2000 | WO2000022143A2 Protein kinase homologs |
| 04/20/2000 | WO2000022135A1 Helicobacter pylori vaccine |
| 04/20/2000 | WO2000022126A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | WO2000022123A1 Novel protein war-1 and gene thereof |
| 04/20/2000 | WO2000022120A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 04/20/2000 | WO2000022119A1 METHOD FOR OBTAINING ACTIVE β-NGF |
| 04/20/2000 | WO2000022111A1 Method for generating diversity |
| 04/20/2000 | WO2000022000A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 04/20/2000 | WO2000021999A1 Novel g protein-coupled receptors |
| 04/20/2000 | WO2000021988A2 Human ankyrin family protein |
| 04/20/2000 | WO2000021979A2 Cyclic tetrapeptide and their use as histone deacetylase inhibitor |
| 04/20/2000 | WO2000021552A1 Glycoprotein antigens, antibodies specific thereto and method for producing same |
| 04/20/2000 | WO2000006605A9 Heterominibodies |
| 04/20/2000 | WO2000004864A3 Agents that bind to and inhibit human cytochrome |
| 04/20/2000 | WO2000004861A3 Agents that bind to and inhibit human cytochrome p450 2a6 |
| 04/20/2000 | WO2000003000A3 Serum-free medium for culturing animal cells |
| 04/20/2000 | WO2000000622A3 Human oxidoreductase proteins |
| 04/20/2000 | WO1999064461A3 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 04/20/2000 | WO1999054463A3 Human k+ ion channel and therapeutic applications thereof |
| 04/20/2000 | WO1999053078A3 Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins |
| 04/20/2000 | DE19848016A1 Production of extracellular microbial protein, particularly esterolytic enzymes, in heterologous bacteria transformed with appropriate nucleic acid and secretory apparatus |
| 04/20/2000 | DE19847690A1 Diagnosing sepsis and severe infections, useful for assessing severity and progress of treatment, by measuring content of peptide prohormone or their derived fragments |
| 04/20/2000 | DE19847628A1 Outer membrane protein of Helicobacter pylori and DNA sequences, useful in vaccines and for production of diagnostic or therapeutic antibodies |
| 04/20/2000 | CA2675802A1 Use of an immunoglobulin-producing cell line to gererate diversity in a gene or gene product |
| 04/20/2000 | CA2347968A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | CA2347121A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 04/20/2000 | CA2347113A1 Human ankyrin family protein |
| 04/20/2000 | CA2346943A1 Cyclic tetrapeptide compound and use thereof |
| 04/20/2000 | CA2346775A1 Protein kinase homologs |
| 04/20/2000 | CA2346713A1 Neisseria genomic sequences and methods of their use |
| 04/20/2000 | CA2344711A1 Expression and secretion of icil-1 receptor antagonist type ii |
| 04/20/2000 | CA2343356A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 04/19/2000 | EP0994188A1 Method for obtaining active beta-NGF |
| 04/19/2000 | EP0994187A1 Renin-active substance comprising human prorerin and antibodies to the prorerin profragment |
| 04/19/2000 | EP0789711B1 Identification of the p21-waf1 -pcna interaction site and therapeutic applications thereof |
| 04/19/2000 | EP0677109B1 Expression system for producing apolipoprotein ai-m |
| 04/19/2000 | EP0667872B1 Mutant interleukin 6 with improved biological activity over wild interleukin 6 |
| 04/19/2000 | EP0598840B1 Human calcium channel compositions and methods |
| 04/19/2000 | EP0550561B1 Purification of cytokeratin fragments |
| 04/19/2000 | EP0222835B2 Oral vaccines |
| 04/19/2000 | CN1251134A Neurotrophic factor NNT-1 |
| 04/19/2000 | CN1250782A Process for preparing antibody able to precisely recognize difference between cells |
| 04/18/2000 | US6051697 Chemokine expressed in eosinophils |